Drugs / IgM-enriched IVIG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04041765 | Sep 2019 → Jun 2020 | neonatal sepsis | Faculty of Medicine, University of Indonesia | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IgM-enriched IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04041765 ↗ |
| Modality | Protein / enzyme biologic | “human plasma protein” NCT04041765 ↗ |
| Route | Intravenous | “Intravenous Immunoglobulin (IVIG)” NCT04041765 ↗ |